DEF 14A: Avinger, Inc. Seeks Stockholder Approval for Warrant Issuance to Comply with Nasdaq Rules

Avinger, Inc. is holding a special meeting of stockholders to approve the issuance of shares upon the exercise of warrants related to a recent best efforts offering, as required by Nasdaq Listing Rule 5635(d).

Summary

• Avinger, Inc. is convening a special meeting of stockholders on August 12, 2024, to vote on two proposals.
• Proposal No. 1 seeks approval for the issuance of common stock upon the exercise of warrants issued in connection with a best efforts offering completed on June 17, 2024.
• This offering included 330,000 shares of common stock, pre-funded warrants for 3,284,457 shares, and several series of warrants (A-1, A-2, and A-3) each for 3,614,457 shares.
• The public offering price was $1.66 per share and accompanying warrants, and $1.659 for each pre-funded warrant and accompanying warrants.
• The warrants have an exercise price of $1.66 per share, while the pre-funded warrants have an exercise price of $0.001 per share.
• The company is obligated to seek stockholder approval under Nasdaq rules because the potential issuance of shares underlying the warrants may not constitute a public offering and certain pricing conditions were not met.
• Proposal No. 2 concerns the adjournment of the Special Meeting, if necessary, to continue soliciting votes in favor of Proposal No. 1.
• The Board of Directors unanimously recommends voting FOR both proposals.

Sentiment

Score: 6

Explanation: The document is primarily procedural, focusing on seeking stockholder approval for a previously completed financing. While there are risks associated with not obtaining approval, the overall tone is neutral.

Positives

• The Board of Directors is proactively seeking stockholder approval to comply with Nasdaq regulations.
• The company has retained Kingsdale Shareholder Services to aid in the solicitation of proxies.

Negatives

• Failure to obtain stockholder approval for the warrant issuance could result in cash obligations for the company, potentially impairing its working capital.
• Non-approval could also negatively impact Avinger's ability to raise equity or debt capital in the future.

Risks

• If Proposal No. 1 is not approved, the warrants would not be exercisable over the 19.99% threshold, potentially leading to cash obligations.
• The inability to exercise the warrants could materially and adversely affect the company's future ability to raise capital.
• A concentration of ownership resulting from the warrant exercises could adversely affect the market price and liquidity of the common stock.
• Sales of common stock issued upon exercise of the warrants could depress the market price of the stock.

Future Outlook

The company is obligated to hold a special meeting every 90 days to seek stockholder approval until it is effective or the warrants are no longer outstanding.

Management Comments

• Our Board of Directors unanimously recommends that our stockholders vote FOR each proposal.
• We appreciate your continued support of Avinger.

Industry Context

This type of request for shareholder approval is common for companies that have recently completed offerings involving warrants, especially when compliance with Nasdaq listing rules is a factor.

Comparison to Industry Standards

• Many small-cap and micro-cap companies that issue warrants as part of their financing packages face similar requirements to obtain shareholder approval to comply with Nasdaq or NYSE listing rules.
• The specific terms of the warrants, such as the exercise price and expiration dates, are typical for these types of offerings.

Stakeholder Impact

• Approval of the proposals could lead to dilution for existing shareholders.
• Failure to approve the proposals could negatively impact the company's financial stability and future prospects, affecting all stakeholders.

Next Steps

• Stockholders are urged to vote on the proposals before the Special Meeting on August 12, 2024.
• The company will announce preliminary voting results at the Special Meeting and disclose final results in a Form 8-K filing.

Key Dates

Keywords

Avinger, stockholder approval, warrants, Nasdaq Listing Rule 5635(d), common stock, special meeting, best efforts offering, proxy statement